These results suggest the potential value of tumor CXCL12 expression as a marker to predict prognosis and to indicate adjuvant chemotherapy after surgical tumor resection in non-small cell lung cancer patients. This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.